Oxford Global Conferences is proud to present the 2nd Annual GPCR’s Congress, which is to be held on the 9th & 10th June 2010 in Montreux, Swtizerland. The congress is the single most focused event in Europe dedicated to key technological and scientific trends in GPCR’s in the pharmaceutical, biotech industry as well as academic institutions.

G-protein coupled receptors have proven to be a highly amenable target class to successful therapeutic intervention via small-molecule drugs. GPCRs represent 25% of the total pharmaceutically-addressed drug targets today and therefore are the most-druggable target family.

This conference therefore explores effective strategies, technologies and applications of GPCR in accelerating drug targeting, discovery and early development. Over two days, the meeting will attract over 100 senior-level decision makers working in drug targeting, design, discovery and development from the UK, Europe and US.  This prestigious event provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment, during a 2 day conference programme

Who you will meet

Delegates are senior practitioners from major pharmaceutical, biopharmaceutical and biotech companies based in Europe and typically include VPs, Directors, Managers  and Senior Scientists of: